Loss of N-acetylglucosaminyl transferase V is involved in the impaired osteogenic differentiation of bone marrow mesenchymal stem cells

The imbalance of bone resorption and bone formation causes osteoporosis (OP), a common skeletal disorder. Decreased osteogenic activity was found in the bone marrow cultures from N-acetylglucosaminyl transferase V (MGAT5)-deficient mice. We hypothesized that MGAT5 was associated with osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) and involved in the pathological mechanisms of osteoporosis. To test this hypothesis, the mRNA and protein expression levels of MGAT5 were determined in bone tissues of ovariectomized (OVX) mice, a well-established OP model, and the role of MGAT5 in osteogenic activity was investigated in murine BMSCs. As expected, being accompanied by the loss of bone mass density and osteogenic markers (runt- related transcription factor 2, osteocalcin and osterix), a reduced expression of MGAT5 in vertebrae and femur tissues were found in OP mice. In vitro, knockdown of Mgat5 inhibited the osteogenic differentiation potential of BMSCs, as evidenced by the decreased expressions of osteogenic markers and less alkaline phosphatase and alizarin red S staining. Mechanically, knockdown of Mgat5 suppressed the nuclear translocation of ss- catenin, thereby downregulating the expressions of downstream genes c- myc and axis inhibition protein 2, which were also associated with osteogenic differentiation. In addition, Mgat5 knockdown inhibited bone morphogenetic protein ( BMP)/transforming growth factor (TGF)-ss signaling pathway. In conclusion, MGAT5 may modulate the osteogenic differentiation of BMSCs via the ss-catenin, BMP type 2 (BMP2) and TGF-ss signals and involved in the process of OP.

Automated summary

The imbalance of bone resorption and bone formation caused osteoporosis. MGAT5 deficiency reduced osteogenic activity in bone marrow cultures. Knockdown of Mgat5 inhibited the osteogenic differentiation of BMSCs and suppressed ss-catenin, BMP2, and TGF-ss signals. MGAT5 may modulate the osteogenic differentiation and contribute to the development of osteoporosis.